- Home
- MTN vs KTTA Comparison
MTN vs KTTA Comparison
Compare MTN & KTTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MTN
- KTTA
- Stock Information
- Founded
- MTN 1997
- KTTA 2020
- Country
- MTN United States
- KTTA United States
- Employees
- MTN N/A
- KTTA N/A
- Industry
- MTN Services-Misc. Amusement & Recreation
- KTTA Biotechnology: Pharmaceutical Preparations
- Sector
- MTN Consumer Discretionary
- KTTA Health Care
- Exchange
- MTN Nasdaq
- KTTA Nasdaq
- Market Cap
- MTN 5.8B
- KTTA 2.8M
- IPO Year
- MTN 1997
- KTTA 2021
- Fundamental
- Price
- MTN $161.06
- KTTA $0.73
- Analyst Decision
- MTN Hold
- KTTA
- Analyst Count
- MTN 10
- KTTA 0
- Target Price
- MTN $186.50
- KTTA N/A
- AVG Volume (30 Days)
- MTN 934.6K
- KTTA 201.2K
- Earning Date
- MTN 06-05-2025
- KTTA 08-12-2025
- Dividend Yield
- MTN 5.51%
- KTTA N/A
- EPS Growth
- MTN 6.60
- KTTA N/A
- EPS
- MTN 7.74
- KTTA N/A
- Revenue
- MTN $2,958,444,000.00
- KTTA N/A
- Revenue This Year
- MTN $3.77
- KTTA N/A
- Revenue Next Year
- MTN $3.71
- KTTA N/A
- P/E Ratio
- MTN $20.80
- KTTA N/A
- Revenue Growth
- MTN 2.38
- KTTA N/A
- 52 Week Low
- MTN $129.85
- KTTA $0.70
- 52 Week High
- MTN $199.45
- KTTA $7.50
- Technical
- Relative Strength Index (RSI)
- MTN 56.30
- KTTA 35.89
- Support Level
- MTN $154.93
- KTTA $0.70
- Resistance Level
- MTN $158.62
- KTTA $0.76
- Average True Range (ATR)
- MTN 3.80
- KTTA 0.04
- MACD
- MTN -0.06
- KTTA 0.01
- Stochastic Oscillator
- MTN 71.47
- KTTA 16.63
About MTN Vail Resorts Inc.
Vail Resorts Inc Bhd is a resorts and casinos company that operates mountain resorts and ski areas. The company has three business segments that include Mountain, Lodging, and Real Estate. The Mountain segment operates numerous ski resort properties that offer a variety of winter and summer activities, such as skiing, snowboarding, snowshoeing, hiking, and mountain biking. The Lodging segment owns and operates hotels and condominiums. The Real Estate segment owns, develops, and leases real estate, typically near its other properties. The company generates the vast majority of its revenue within the United States.
About KTTA Pasithea Therapeutics Corp.
Pasithea Therapeutics Corp is a biotechnology company. It is focused on the discovery, research, and development of treatments for central nervous system (CNS) disorders and other diseases, including RASopathies and certain cancers. It leveraging in the fields of neuroscience, translational medicine, and drug development. Its pipeline includes Neurofibromatosis Type 1, Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis (MS), and Schizophrenia. Companies pipelines includes PAS-004 (Macrocyclic Small Module[MEK1/2]), PAS-003 (Monoclonal antibody),PAS-001 (Small Module).